Searched for
DIVIS LABORATORIES RESULTS
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Divi's Laboratories Q4 Results: Cons PAT grows 13% YoY to Rs 751 crore, revenue up 10%; Rs 30 per share dividend announcedDivi's Laboratories Q4 Results: Divi's Laboratories announced strong financial results for the March quarter. Net profit rose 13% to Rs 751...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Divi’s Laboratories Q2 Results: Cons profit jumps 35% YoY to Rs 689 crore, revenue up 16%Divi's Laboratories reported a robust financial performance for the second quarter of FY26, with consolidated net profit soaring by 35% yea...
- Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14%Divi’s Laboratories Q1 Results: The Hyderabad-based pharma giant posted a consolidated revenue of ₹2,410 crore from operations in the first...
- Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest?Divi's Laboratories reported a strong Q4FY25, with a 26% YoY increase in net profit to Rs 667 crore and a 12.26% rise in revenue to Rs 2,53...
- Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit...
- Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25%Divi's Labs Q3 Results: Divi's Laboratories reported a significant 64% year-on-year increase in its December quarter net profit, reaching R...
- Divi’s Laboratories Q2 Results: Company posts 47% jump in net profit in Q2FY25Divi's Laboratories witnessed a 46.6% surge in profit, reaching Rs. 510 crores in Q2FY25, fueled by robust growth in their custom synthesis...
- Divi's Laboratories Q2 Results: PAT jumps 46% YoY to Rs 510 crore on forex gainDivi's Laboratories Q2 Results: The company reported a 22.5% year-on-year revenue increase in Q2, reaching Rs 2,338 crore, up from Rs 1,909...
- Divi’s Laboratories shares rally 5% post Q4 results. Should you buy, sell or hold?Divi’s Laboratories saw a 5% surge in its shares on the BSE during Monday's trading session, reaching a new 52-week high of Rs 4,335. This ...
- Divi's Laboratories Q4 Results: Cons PAT soars 68% YoY to Rs 538 crore; dividend declared at Rs 30 per shareDivi's Laboratories Q4 Results: Net profit stood at Rs 321 crore in the corresponding quarter of the last financial year. The consolidated ...
- Q3 Results Today: Divi’s Lab, ONGC, MCX among 170 companies to announce earningsAmong other important results will be those by Aurobindo Pharma, Chemcon Speciality Chemicals, Sai Silks (Kalamandir), Mawana Sugars, MM Fo...
- Divi's Lab shares jump over 9% as exports rise in MarchThe consensus recommendation from 23 analysts for Divi's Lab is Sell. Out of these analysts, only six have strong buy and buy ratings, whil...
- Divi’s Labs Q4 Results: Profit surges 78% YoY to Rs 895 crore, beats estimatesThe Board of Directors of the company has recommended a dividend of Rs 30 per share for the financial year 2021-22, subject to approval of ...
- Divi's Labs shares fall 9% post Sept quarter numbers; here's whyWe envisage near term pressures growin for Divi's Labs, with rising raw material prices, logistical issues and declining generics business,...
- Divi’s Labs hits all-time high after robust Q2 resultsA recent entrant to the Nifty pack, Divi’s Labs is up 82 per cent year-to-date, and has almost doubled over the last one year.
- Divi's Laboratories shares zoom over 18% after Q1 resultsShares of Divi's Laboratories on Monday rallied over 18 per cent after the company reported 80.61 per cent rise in consolidated net profit ...
- Divi's Laboratories shares down nearly 3 per cent post earningsShares of drug firm Divi's Laboratories fell by nearly 3% after the company's first quarter results failed to meet market expectations.
- Divi's Lab shares down over 4% post earningsDivi's Laboratories had yesterday reported a standalone net profit of Rs 167.93 crore for the first quarter ended June 30.
Load More
